The Chief Minister's Office of Himachal Pradesh on Thursday, 9 July 2026 issued a set of key directives to senior officials covering the state's Bulk Drug Park project and industrial infrastructure, while also confirming that the first instalment of Rs 66 crore for the Unity Mall has been disbursed.

Context

The post, shared from the official CMO Himachal Pradesh handle, outlined instructions given to officers on two fronts: attracting investment into the Bulk Drug Park and completing critical shared infrastructure by a firm deadline. Translated from Hindi, the directives state: 'देश की प्रतिष्ठित कंपनियों को आमंत्रित किया जाए' ('reputed companies of the country should be invited') to invest in the Bulk Drug Park. The second directive sets 15 July as the deadline for completing work on the Common Effluent Treatment Plant (CETP) and the Steam Generation facility.

The simultaneous release of Rs 66 crore as the first instalment for the Unity Mall signals that the state government is advancing multiple industrial and commercial infrastructure projects concurrently.

Policy Backdrop

The Bulk Drug Park scheme was approved by the Union Cabinet in 2020 under the Department of Pharmaceuticals, with financial assistance earmarked for states to build shared infrastructure for manufacturing Active Pharmaceutical Ingredients (APIs). The scheme was designed to reduce India's heavy dependence on API imports, particularly from China, a concern that gained urgency following global supply chain disruptions.

Himachal Pradesh has been among the states actively pursuing such greenfield industrial parks. A Common Effluent Treatment Plant is a mandated environmental compliance facility for pharma and chemical clusters, ensuring industrial wastewater is treated collectively before discharge. The Steam Generation facility provides shared energy infrastructure, lowering costs for individual units within the park.

Stakeholders and Impact

The primary beneficiaries of a functional Bulk Drug Park are domestic pharmaceutical manufacturers seeking integrated, compliant infrastructure to set up API production units. The directive to invite 'reputed companies of the country' suggests the state is targeting established players rather than start-ups, aiming to anchor the park with credible anchor investors.

Completion of the CETP and Steam Generation facility by 15 July is a prerequisite for the park to become investor-ready. Delays in such shared utilities have historically stalled private investment decisions in similar industrial clusters across India. For Himachal Pradesh, successful operationalisation would generate industrial employment and strengthen the state's position as a pharma manufacturing hub in northern India.

The Unity Mall component, now backed by a confirmed Rs 66 crore first instalment, is a separate initiative aimed at promoting local artisans and products — a scheme the central government has encouraged states to develop as a platform for 'One District One Product' and similar indigenous goods.

What's Next

The immediate watch point is whether the CETP and Steam Generation works are completed by the stated 15 July deadline, which is less than a week away from the date of this announcement. Officials will also be expected to formally reach out to major pharmaceutical companies with investment proposals for the Bulk Drug Park.

Broader progress on the Unity Mall project — including timelines for construction and operationalisation — will determine how quickly the Rs 66 crore disbursement translates into on-ground delivery. Himachal Pradesh's ability to meet these self-imposed deadlines will be a test of administrative momentum on two high-visibility infrastructure tracks simultaneously.